天华新能(300390) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥1,739,581,121.78, representing a decrease of 23.33% compared to the same period last year[2]. - The net profit attributable to shareholders for Q3 2024 was ¥88,429,696.45, down 80.22% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥80,185,665.89, a decrease of 77.00% compared to the previous year[2]. - The basic earnings per share for Q3 2024 was ¥0.11, a decrease of 79.25% year-on-year[2]. - The diluted earnings per share for Q3 2024 was also ¥0.11, reflecting a 79.25% decline compared to the same period last year[4]. - Total operating revenue for Q3 2024 was CNY 5,452,775,594.77, a decrease of 38.5% compared to CNY 8,910,441,366.29 in the same period last year[21]. - Net profit for Q3 2024 was approximately 1,117.05 million, down 52.5% from 2,347.90 million in Q3 2023[22]. - Basic and diluted earnings per share for Q3 2024 were both 1.10, compared to 2.18 in Q3 2023[23]. - The comprehensive income for Q3 2024 was approximately 1,012.99 million, down 55.7% from 2,287.08 million in Q3 2023[23]. Assets and Liabilities - The total assets at the end of the reporting period were ¥18,068,513,048.82, a decline of 4.23% from the end of the previous year[3]. - The equity attributable to shareholders at the end of the reporting period was ¥11,924,424,003.97, down 0.23% from the previous year[3]. - Total assets decreased to CNY 18,068,513,048.82 from CNY 18,866,120,267.36, a decline of 4.2%[19]. - Total liabilities decreased to CNY 3,379,569,039.77 from CNY 4,316,104,083.12, a reduction of 21.7%[20]. - Non-current assets totaled CNY 8,341,320,178.32, an increase from CNY 8,046,727,327.91, reflecting a growth of 3.7%[19]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥1,099,994,611.41, down 69.86% year-on-year[2]. - The net cash flow from operating activities for Q3 2024 was ¥1,099,994,611.41, a decrease of 69.9% compared to ¥3,649,275,531.42 in Q3 2023[25]. - The net cash flow from investing activities was -¥1,780,051,554.26, slightly improved from -¥1,909,190,353.71 in the same period last year[25]. - The net cash flow from financing activities was -¥1,593,436,800.51, compared to -¥2,023,841,166.57 in Q3 2023, indicating a reduction in cash outflow[25]. - The total cash and cash equivalents at the end of Q3 2024 stood at ¥4,601,147,710.18, down from ¥8,042,935,222.78 at the end of Q3 2023[26]. - The company reported a total cash outflow from operating activities of ¥5,239,208,394.61, compared to ¥6,898,629,683.33 in the previous year, reflecting a decrease of 24%[25]. - Cash inflow from investment activities was ¥4,115,459,149.27, a significant increase from ¥526,429,204.44 in Q3 2023[25]. - The company experienced a net decrease in cash and cash equivalents of ¥2,287,822,535.50 in Q3 2024, compared to a decrease of ¥248,385,099.14 in Q3 2023[26]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 76,655[9]. - The largest shareholder, Pei Zhenhua, holds 23.69% of the shares, amounting to 196,835,843 shares[9]. - The company’s total share capital decreased from 842,528,008 shares to 830,750,788 shares after the cancellation of repurchased shares[16]. - The company’s major shareholders include China Industrial Bank and China Agricultural Bank, holding 0.84% and 0.39% of the shares, respectively[11]. - The company’s major shareholders participating in the securities lending business have not returned shares, accounting for 0.20% of the total share capital[11]. Share Repurchase - The company plans to repurchase shares with a total fund of no less than ¥150 million and no more than ¥250 million, with a maximum repurchase price of ¥39.5 per share[14]. - The company has completed the repurchase of 11,777,220 shares, accounting for 1.40% of the total share capital, with a total transaction amount of ¥249,968,436.10[15]. - The company’s stock repurchase plan is set to be implemented within 12 months from the board's approval date[14]. Operational Costs and Expenses - Total operating costs for Q3 2024 were CNY 4,799,974,089.13, down 27.3% from CNY 6,597,949,934.50 year-over-year[21]. - Research and development expenses for Q3 2024 were approximately 66.88 million, slightly up from 66.18 million in Q3 2023[22]. - Sales expenses increased to approximately 35.30 million in Q3 2024 from 31.17 million in Q3 2023, reflecting a rise of 13.3%[22]. - Financial expenses showed a significant improvement, with a net income of approximately -54.79 million in Q3 2024 compared to -127.49 million in Q3 2023[22]. - The company reported an asset impairment loss of approximately 203.29 million in Q3 2024, compared to a gain of 7.19 million in Q3 2023[22].